Last update 22 Dec 2024

ATTCK-20

Overview

Basic Info

Drug Type
Antibody-Coupled T Cell Receptor Therapy
Synonyms
Antibodycoupled Tcell receptor antiCD20 immunotherapy Cogent Biosciences, mRNA ACTR Tcells + rituximab, ATTCK 20
+ [1]
Target
CD20
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), Immunologic cytotoxicity, Immunostimulants
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Originator Organization
Cogent Biosciences, Inc.Cogent Biosciences, Inc.
Active Organization-
Inactive Organization
Singapore General Hospital Pte Ltd.Singapore General Hospital Pte Ltd.Cogent Biosciences, Inc.Cogent Biosciences, Inc.National University HospitalNational University Hospital
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with ATTCK-20
Login to view more data
100 Translational Medicine associated with ATTCK-20
Login to view more data
100 Patents (Medical) associated with ATTCK-20
Login to view more data
100 Deals associated with ATTCK-20
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Lymphocytic LeukemiaPhase 1
SG
Singapore General Hospital Pte Ltd.Singapore General Hospital Pte Ltd.
-
Chronic Lymphocytic LeukemiaPhase 1
SG
Cogent Biosciences, Inc.Cogent Biosciences, Inc.
-
Chronic Lymphocytic LeukemiaPhase 1
SG
National University HospitalNational University Hospital
-
Non-Hodgkin LymphomaPhase 1
SG
National University HospitalNational University Hospital
-
Non-Hodgkin LymphomaPhase 1
SG
Singapore General Hospital Pte Ltd.Singapore General Hospital Pte Ltd.
-
Non-Hodgkin LymphomaPhase 1
SG
Cogent Biosciences, Inc.Cogent Biosciences, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free